Subrata Shaw
Subrata Shaw
Broad Institute of MIT and Harvard
Verified email at broadinstitute.org - Homepage
TitleCited byYear
A new catalyst for the asymmetric Henry reaction: synthesis of β-nitroethanols in high enantiomeric excess
S Shaw, JD White
Organic Letters 14 (24), 6270-6273, 2012
792012
Discovery of 2-indole-acylsulfonamide myeloid cell leukemia 1 (Mcl-1) inhibitors using fragment-based methods
NF Pelz, Z Bian, B Zhao, S Shaw, JC Tarr, J Belmar, C Gregg, ...
Journal of medicinal chemistry 59 (5), 2054-2066, 2016
612016
Discovery of tricyclic indoles that potently inhibit Mcl-1 using fragment-based methods and structure-based design
JP Burke, Z Bian, S Shaw, B Zhao, CM Goodwin, J Belmar, CF Browning, ...
Journal of medicinal chemistry 58 (9), 3794-3805, 2015
512015
Cis-2,5-Diaminobicyclo [2.2. 2] octane, a New Scaffold for Asymmetric Catalysis via Salen-Metal Complexes
S Shaw, JD White
Organic letters 13 (9), 2488-2491, 2011
392011
A New Iron (III)–Salen Catalyst for Enantioselective Conia-ene Carbocyclization
S Shaw, JD White
Journal of the American Chemical Society 136 (39), 13578-13581, 2014
332014
Iron catalyzed enantioselective sulfa-Michael addition: a four-step synthesis of the anti-asthma agent Montelukast
S Shaw, JD White
Chemical Science 5 (6), 2200-2204, 2014
332014
Discovery and biological characterization of potent myeloid cell leukemia‐1 inhibitors
T Lee, Z Bian, B Zhao, LJ Hogdal, JL Sensintaffar, CM Goodwin, J Belmar, ...
FEBS letters 591 (1), 240-251, 2017
272017
A New Cobalt–Salen Catalyst for Asymmetric Cyclopropanation. Synthesis of the Serotonin–Norepinephrine Repuptake Inhibitor (+)-Synosutine
S Shaw, JD White
Organic letters 16 (15), 3880-3883, 2014
272014
Regioselective and Enantioselective Addition of Sulfur Nucleophiles to Acyclic α, β, γ, δ-Unsaturated Dienones Catalyzed by an Iron (III)–Salen Complex
S Shaw, JD White
Organic letters 17 (18), 4564-4567, 2015
162015
Asymmetric Catalysis with Iron–Salen Complexes
S Shaw, JD White
Synthesis 48 (17), 2768-2780, 2016
102016
Andrographolide, a diterpene lactone from Andrographis paniculata and its therapeutic promises in cancer
MT Islam, ES Ali, SJ Uddin, MA Islam, S Shaw, IN Khan, SSS Saravi, ...
Cancer letters 420, 129-145, 2018
82018
A comprehensive review on biological properties of citrinin
JWG de Oliveira Filho, MT Islam, ES Ali, SJ Uddin, JV de Oliveira Santos, ...
Food and Chemical Toxicology 110, 130-141, 2017
82017
Optimization of potent and selective tricyclic indole diazepinone myeloid cell leukemia-1 inhibitors using structure-based design
S Shaw, Z Bian, B Zhao, JC Tarr, N Veerasamy, KO Jeon, J Belmar, ...
Journal of medicinal chemistry 61 (6), 2410-2421, 2018
72018
Cis-2,5-Diaminobicyclo [2.2.2] octane, a New Chiral Scaffold for Asymmetric Catalysis
S Shaw, JD White
Accounts of chemical research 49 (9), 1825-1834, 2016
72016
Phytol: A review of biomedical activities
MT Islam, ES Ali, SJ Uddin, S Shaw, MA Islam, MI Ahmed, MC Shill, ...
Food and chemical toxicology 121, 82-94, 2018
62018
Small molecule Mcl-1 inhibitors induce apoptosis and death in multiple cancer subtypes in vitro
JL Sensintaffar, A Arnold, C Goodwin, L Hogdal, S Shaw, JC Tarr, T Lee, ...
Cancer Research 76 (14 Supplement), 3727-3727, 2016
22016
High Throughput Screen Identifies Interferon γ-Dependent Inhibitors of Toxoplasma gondii Growth
JB Radke, KL Carey, S Shaw, SR Metkar, C Mulrooney, JP Gale, ...
ACS infectious diseases 4 (10), 1499-1507, 2018
12018
Discovery of orally bioavailable novel Mcl-1 inhibitors that exhibit selective anti-proliferative activity in Mcl-1 sensitive cancer cell lines
T Lee, Z Bian, J Belmar, S Shaw, JC Tarr, B Zhao, N Pelz, DM Camper, ...
Cancer Research 76 (14 Supplement), 3551-3551, 2016
12016
Cis-2,5-diaminobicyclo [2.2.2] octane: a novel C₂-symmetric scaffold for asymmetric catalysis
S Shaw
12014
A systematic review on the neuroprotective perspectives of beta‐caryophyllene
KC Machado, MT Islam, ES Ali, R Rouf, SJ Uddin, S Dev, JA Shilpi, ...
Phytotherapy Research 32 (12), 2376-2388, 2018
2018
The system can't perform the operation now. Try again later.
Articles 1–20